Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2017
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian CancerGemma L Owens, Victoria E Sheard, Milena Kalaitsidou, et al.
Human Gene Therapy|October 7, 2016
Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) StudyPeter A Campochiaro, Andreas K Lauer, Elliott H Sohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trialRichard Harrop, Noel Connolly, Irina Redchenko, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2011
MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patientsRichard Harrop, William H Shingler, Mike McDonald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responsesRichard Harrop, Noel Drury, William Shingler, et al.
Journal of Translational Medicine|January 9, 2009
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinomaHoward L Kaufman, Bret Taback, William Sherman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastasesEyad Elkord, Adam Dangoor, Noel L Drury, et al.
Plos One|January 6, 2007
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancerSarah L Clarke, Gareth J Betts, Andrea Plant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 17, 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)Agnieszka Michael, William Wilson, Sunny Sunshine, et al.
Pageof 4